Wall Street Analysts Think Insulet (PODD) Could Surge 53.28%: Read This Before Placing a BetZacks Investment Research • 11/06/23
Insulet Surges After Eye-Popping Earnings Growth Wallops ExpectationsInvestors Business Daily • 11/03/23
Insulet Reports Third Quarter 2023 Revenue Increase of 27% Year-Over-Year (25% Constant Currency1)Business Wire • 11/02/23
Insulet Spotlights Diabetes Awareness on World Diabetes Day and Throughout NovemberBusiness Wire • 11/01/23
Diabetes stocks jump as obesity-drug recovery comes ahead of schedule, analysts sayMarket Watch • 10/27/23
Insulet (PODD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 10/26/23
The weight-loss drugs are coming for these companies — but here's why Coke, others, may be spared, says JPMorganMarket Watch • 10/24/23
Down -20.51% in 4 Weeks, Here's Why Insulet (PODD) Looks Ripe for a TurnaroundZacks Investment Research • 10/17/23
Down -21.98% in 4 Weeks, Here's Why Insulet (PODD) Looks Ripe for a TurnaroundZacks Investment Research • 10/16/23